Related Experiment Video

Updated: May 29, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling

Xinhua Pan1, Honghui Han, Lei Wang

  • 1The Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China.

Cancer Letters
|October 1, 2011
PubMed

Insights

Nitidine Chloride (NC) effectively inhibits breast cancer cell migration and invasion. This novel compound shows potential as an anti-metastasis drug by targeting key cellular pathways involved in cancer spread.

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Nitidine is a benzophenanthridine alkaloid with known anti-tumor properties.
  • Cancer metastasis remains a significant challenge in breast cancer treatment.

Purpose of the Study:

  • To investigate the anti-metastatic effects of Nitidine Chloride (NC) on breast cancer cells.
  • To elucidate the molecular mechanisms underlying NC's action.

Main Methods:

  • In vitro and in vivo studies using breast cancer cell lines (MDA-MB-231).
  • Assays for cell migration, invasion, and matrix metalloproteinase (MMP) activity.
  • Western blotting to assess protein phosphorylation and activation of signaling pathways (c-Src, FAK, MAPKs, RhoA, Rac1, AP-1).

Main Results:

  • NC significantly inhibited breast cancer cell migration and invasion.
  • NC dose-dependently attenuated protrusion formation and MMP-2/MMP-9 activity.
  • NC decreased PDGF-induced phosphorylation of c-Src, FAK, MAPKs, and inhibited RhoA, Rac1 activation and AP-1 transcriptional activity.

Conclusions:

  • Nitidine Chloride demonstrates potent anti-metastatic properties in breast cancer.
  • NC acts by inhibiting key signaling pathways crucial for cancer cell motility and invasion.
  • NC holds promise as a novel therapeutic agent for preventing breast cancer metastasis.

More Related Videos

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells11:06

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on: May 20, 2015

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...